sotorasib
amgen
['codebreak200', 'lcsm,(-blcsm)']
#esmo22 codebreak200 in pres iii: 1-year pfs: 24.8% vs 10.1% mpfs hr 0.66 (0.51-0.86) hr for cns: 0.53! dcr: 82.5 vs 60.3% , crossover 26+8=34% / mos ns toxic favours soto not powered for os humbled to have served this global effort #some #lcsm 
#MedicalOncologist MSc Transl Res Univ Paris Sud   #LungCancer biology, immunotherapy, clinical trials #LCSM @myESMO faculty #OncoAlert   live to give